Statin use linked to reduced risk of hepatocellular cancer

February 12, 2013
Statin use linked to reduced risk of hepatocellular cancer
Statin use is associated with a reduced risk of hepatocellular carcinoma, most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

(HealthDay)—Statin use is associated with a reduced risk of hepatocellular carcinoma (HCC), most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

Siddharth Singh, M.B.B.S., from the Mayo Clinic in Rochester, Minn., and colleagues conducted a systematic literature review and meta-analysis of studies that evaluated the effects of statins on the risk of HCC. The analysis included 10 studies reporting 4,298 cases of HCC in 1,459,417 patients.

The researchers found that, compared with statin nonusers, statin users were significantly less likely to develop HCC (adjusted odds ratio [aOR], 0.63), although there was considerable heterogeneity in the results (P = 0.01; I² = 59 percent). Suggested sources of this heterogeneity included study location (Asian population [four studies]: aOR, 0.52; Western population [six studies]: aOR, 0.67) and study design ( [seven studies]: aOR, 0.60; clinical trials [three studies]: aOR, 0.95; 95 percent confidence interval, 0.62 to 1.45).

"In summary, our meta-analysis suggests that use of statins is associated with a reduced risk of HCC," the authors write. "However, these results should be interpreted with caution given the possibility of residual confounding. Future randomized clinical trials or prospective cohort studies in populations at high risk for HCC (especially in the Asian -infected population) are warranted."

Explore further: Family history of liver cancer increases risk of developing the disease

More information: Abstract
Full Text

Related Stories

Incidence of recurrent anal sphincter rupture is 7.1 percent

October 26, 2012

(HealthDay)—The incidence of recurrent anal sphincter rupture (ASR) is 7.1 percent, and several risk factors are associated with an increased risk, including excessive birth weight, vacuum extraction, and shoulder dystocia, ...

Recommended for you

New role for an old protein: Cancer causer

September 3, 2015

A protein known to play a role in transporting the molecular contents of normal cells into and out of various intracellular compartments can also turn such cells cancerous by stimulating a key growth-control pathway.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.